{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:30:15Z","timestamp":1787027415339,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.mtbio.2026.103505","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:53:17Z","timestamp":1785253997000},"page":"103505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Linker-directed lipid-antigen conjugates co-enhance lymph node targeting and antigen presentation for potent T cell immunity"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4053-853X","authenticated-orcid":false,"given":"Junfei","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licheng","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiating","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zigong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mtbio.2026.103505_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-024-02107-5","article-title":"Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines","volume":"10","author":"Xiao","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.mtbio.2026.103505_bib2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mtbio.2026.103505_bib3","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1021\/acs.chemrev.9b00472","article-title":"Peptide-based vaccines: current progress and future challenges","volume":"120","author":"Malonis","year":"2020","journal-title":"Chem. Rev."},{"key":"10.1016\/j.mtbio.2026.103505_bib4","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41392-023-01674-3","article-title":"Therapeutic cancer vaccines: advancements, challenges and prospects","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.mtbio.2026.103505_bib5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41577-023-00937-y","article-title":"Challenges in developing personalized neoantigen cancer vaccines","volume":"24","author":"Katsikis","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mtbio.2026.103505_bib6","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41586-021-04232-5","article-title":"A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity","volume":"601","author":"Heitmann","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.mtbio.2026.103505_bib7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41586-018-0792-9","article-title":"Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial","volume":"565","author":"Keskin","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.mtbio.2026.103505_bib8","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1158\/1078-0432.CCR-21-4424","article-title":"Phase I\/II multicenter trial of a novel therapeutic cancer vaccine, HepaVac-101, for hepatocellular carcinoma","volume":"28","author":"L\u00f6ffler","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mtbio.2026.103505_bib9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13045-025-01670-w","article-title":"Cancer vaccines: current status and future directions","volume":"18","author":"Zhou","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.mtbio.2026.103505_bib10","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2204078119","article-title":"Cell-penetrating peptides enhance peptide vaccine accumulation and persistence in lymph nodes to drive immunogenicity","volume":"119","author":"Backlund","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.mtbio.2026.103505_bib11","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12951-023-01977-1","article-title":"Targeting lymph node delivery with nanovaccines for cancer immunotherapy: recent advances and future directions","volume":"21","author":"Li","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.mtbio.2026.103505_bib12","article-title":"Old concepts, new tricks: how peptide vaccines are reshaping cancer immunotherapy?","author":"Liu","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.mtbio.2026.103505_bib13","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1021\/acsnano.7b00978","article-title":"Efficient nanovaccine delivery in cancer immunotherapy","volume":"11","author":"Zhu","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2026.103505_bib14","article-title":"In situ cocktail nanovaccine for cancer immunotherapy","volume":"10","author":"Liu","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.mtbio.2026.103505_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202400068","article-title":"Genetically engineered cytomembrane nanovaccines for cancer immunotherapy","volume":"13","author":"Pan","year":"2024","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.mtbio.2026.103505_bib16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41568-019-0186-9","article-title":"Improving cancer immunotherapy through nanotechnology","volume":"19","author":"Goldberg","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mtbio.2026.103505_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jconrel.2017.08.009","article-title":"Lymph node targeting strategies to improve vaccination efficacy","volume":"267","author":"Jiang","year":"2017","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103505_bib18","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1016\/j.apsb.2023.01.006","article-title":"Advanced subunit vaccine delivery technologies: from vaccine cascade obstacles to design strategies","volume":"13","author":"Hou","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.mtbio.2026.103505_bib19","doi-asserted-by":"crossref","first-page":"30540","DOI":"10.1021\/acsnano.4c08922","article-title":"Glycopolymeric nanoparticles enrich less immunogenic protein coronas, reduce mononuclear phagocyte clearance, and improve tumor delivery compared to PEGylated nanoparticles","volume":"18","author":"Hulugalla","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2026.103505_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s44222-025-00321-6","article-title":"Polyethylene glycol immunogenicity in nanomedicine","author":"Chen","year":"2025","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.mtbio.2026.103505_bib21","doi-asserted-by":"crossref","first-page":"24724","DOI":"10.1021\/acsnano.4c16908","article-title":"Polyethylene-Glycol-conjugated peptide coacervates with tunable size for intracellular mRNA delivery","volume":"19","author":"Sun","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2026.103505_bib22","doi-asserted-by":"crossref","first-page":"22240","DOI":"10.1021\/acsnano.5c03978","article-title":"Multilayered nanoarchitectonics of poly(ethylene glycol) nanoparticles with tunable stiffness modulate bio\u2013nano interactions and targeted drug delivery","volume":"19","author":"Li","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2026.103505_bib23","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jconrel.2022.06.025","article-title":"Modulating albumin-mediated transport of peptide-drug conjugates for antigen-specific Treg induction","volume":"348","author":"Lau","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103505_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2014.12.024","article-title":"Cationic micelle delivery of Trp2 peptide for efficient lymphatic draining and enhanced cytotoxic T-lymphocyte responses","volume":"200","author":"Zeng","year":"2015","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103505_bib25","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jconrel.2023.10.002","article-title":"Battle of the Milky Way: lymphatic targeted drug delivery for pathogen eradication","volume":"363","author":"Taheri","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103505_bib26","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1021\/acs.accounts.0c00456","article-title":"Engineered nanoparticles for cancer vaccination and immunotherapy","volume":"53","author":"Aikins","year":"2020","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.mtbio.2026.103505_bib27","doi-asserted-by":"crossref","first-page":"9826","DOI":"10.1021\/acsnano.3c02273","article-title":"Stimuli-responsive polymeric nanovaccines toward next-generation immunotherapy","volume":"17","author":"Mao","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2026.103505_bib28","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2022.09.015","article-title":"Lymph node-targeting nanovaccines for cancer immunotherapy","volume":"351","author":"Wang","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103505_bib29","doi-asserted-by":"crossref","first-page":"16694","DOI":"10.1021\/jacs.5c05312","article-title":"Click chemistry-assisted rejuvenation of aging T cells sensitizes aged mice to tumor immunotherapy","volume":"147","author":"Bai","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.mtbio.2026.103505_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-025-01400-0","article-title":"Potentiating cancer immunotherapies with modular albumin-hitchhiking nanobody\u2013STING agonist conjugates","author":"Kimmel","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.mtbio.2026.103505_bib31","article-title":"Albumin-Hitchhiking drug delivery to tumor-draining lymph nodes precisely boosts tumor-specific immunity through autophagy modulation of immune cells","volume":"35","author":"Wang","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2026.103505_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202006007","article-title":"Development of a cancer vaccine using in vivo click\u2010chemistry\u2010mediated active lymph Node accumulation for improved immunotherapy","volume":"33","author":"Qin","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2026.103505_bib33","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/s41467-017-02191-y","article-title":"Albumin\/Vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy","volume":"8","author":"Zhu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2026.103505_bib34","article-title":"Albumin-recruiting lipid nanoparticle potentiates the safety and efficacy of mRNA vaccines by avoiding liver accumulation","author":"Feng","year":"2025","journal-title":"Nat. Mater."},{"key":"10.1016\/j.mtbio.2026.103505_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn1413","article-title":"Intranasal vaccination with lipid-conjugated immunogens promotes antigen transmucosal uptake to drive mucosal and systemic immunity","volume":"14","author":"Hartwell","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.mtbio.2026.103505_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe5819","article-title":"A lymph node-targeted amphiphile vaccine induces potent cellular and humoral immunity to SARS-CoV-2","volume":"7","author":"Steinbuck","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mtbio.2026.103505_bib37","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature12978","article-title":"Structure-based programming of lymph-node targeting in molecular vaccines","volume":"507","author":"Liu","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.mtbio.2026.103505_bib38","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1158\/2326-6066.CIR-17-0607","article-title":"Enhancement of peptide vaccine immunogenicity by increasing lymphatic drainage and boosting serum stability","volume":"6","author":"Moynihan","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.mtbio.2026.103505_bib39","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41591-023-02760-3","article-title":"Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial","volume":"30","author":"Pant","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.mtbio.2026.103505_bib40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2020.07.046","article-title":"Lymphatic targeting by albumin-hitchhiking: applications and optimization","volume":"327","author":"Abdallah","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103505_bib41","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jconrel.2022.11.034","article-title":"Albumin-hitchhiking: fostering the pharmacokinetics and anticancer therapeutics","volume":"353","author":"Famta","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103505_bib42","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.1021\/acsnano.4c18636","article-title":"Ionizable lipids with optimized linkers enable Lung-Specific, lipid nanoparticle-mediated mRNA delivery for treatment of metastatic lung tumors","volume":"19","author":"Somu Naidu","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2026.103505_bib43","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1038\/s41467-024-45609-0","article-title":"Structural optimization of siRNA conjugates for albumin binding achieves effective MCL1-directed cancer therapy","volume":"15","author":"Hoogenboezem","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2026.103505_bib44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41573-022-00529-w","article-title":"Derivatization with fatty acids in peptide and protein drug discovery","volume":"22","author":"Kurtzhals","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mtbio.2026.103505_bib45","doi-asserted-by":"crossref","first-page":"6126","DOI":"10.1021\/jm070861j","article-title":"Structure-activity and protraction relationship of long-acting glucagon-like Peptide-1 derivatives: importance of Fatty acid length, polarity, and bulkiness","volume":"50","author":"Madsen","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mtbio.2026.103505_bib46","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1021\/acs.bioconjchem.8b00463","article-title":"Long-acting human growth hormone analogue by noncovalent albumin binding","volume":"29","author":"Ram\u00edrez-Andersen","year":"2018","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.mtbio.2026.103505_bib47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jconrel.2022.05.038","article-title":"Molecular analysis and therapeutic applications of human serum albumin-fatty acid interactions","volume":"348","author":"Linciano","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103505_bib48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s40265-023-01977-3","article-title":"Zilucoplan: first approval","volume":"84","author":"Shirley","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.mtbio.2026.103505_bib49","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/eji.200737995","article-title":"Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation","volume":"38","author":"Bijker","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.mtbio.2026.103505_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115675","article-title":"Challenges and opportunities on achieving an adequate delivery efficiency and immunogenicity with peptide-based anticancer vaccines","volume":"225","author":"Wang","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mtbio.2026.103505_bib51","doi-asserted-by":"crossref","first-page":"15867","DOI":"10.1002\/chem.202003951","article-title":"Improving the stability of maleimide-thiol conjugation for drug targeting","volume":"26","author":"Lahnsteiner","year":"2020","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.mtbio.2026.103505_bib52","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41586-025-08758-w","article-title":"STING agonist-based ER-targeting molecules boost antigen cross-presentation","volume":"641","author":"Wang","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.mtbio.2026.103505_bib53","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jconrel.2012.04.002","article-title":"Effect of unsaturated alkyl chains on transfection activity of poly(amidoamine) dendron-bearing lipids","volume":"160","author":"Yuba","year":"2012","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2026.103505_bib54","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.actbio.2022.12.058","article-title":"Systematic modulation of the lipid composition enables the tuning of liposome cellular uptake","volume":"158","author":"Mateos-Maroto","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.mtbio.2026.103505_bib55","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41467-023-35948-9","article-title":"IFN\u03b3 signaling in cytotoxic T cells restricts anti-tumor responses by inhibiting the maintenance and diversity of intra-tumoral stem-like T cells","volume":"14","author":"Mazet","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2026.103505_bib56","doi-asserted-by":"crossref","first-page":"e2836","DOI":"10.1038\/cddis.2017.67","article-title":"Interferon-\u03b3 derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity","volume":"8","author":"Bhat","year":"2017","journal-title":"Cell Death Dis."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426007507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426007507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:11:47Z","timestamp":1787026307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006426007507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":56,"alternative-id":["S2590006426007507"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103505","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Linker-directed lipid-antigen conjugates co-enhance lymph node targeting and antigen presentation for potent T cell immunity","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103505"}}